ModeX Therapeutics

ModeX Therapeutics is a private biotechnology company focused on developing multispecific immunotherapies for cancer and infectious diseases. The company offers cancer immunotherapies, multispecific antibodies for HIV and SARS-CoV-2, tumor-specific cytotoxic antibodies, and an undeveloped Epstein-Barr virus vaccine, enabling customers to leverage a variety of multifunctional antibody drugs for cancer and infectious diseases.